Page 125 - Read Online
P. 125

Page 262                                          Dana et al. J Transl Genet Genom 2020;4:251-62  I  http://dx.doi.org/10.20517/jtgg.2020.25

               84.  Xing X, Zhang J, Wu K, Cao B, Li X, et al. Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice.
                   Sci Rep 2019;9:3041.
               85.  Zhu JW, Zou MM, Li YF, Chen WJ, Liu JC, et al. Absence of TRIM32 leads to reduced GABAergic interneuron generation and autism-
                   like behaviors in mice via suppressing mTOR signaling. Cereb Cortex 2020;30:3240-58.
               86.  Ornoy A, Weinstein-Fudim L, Ergaz Z. Prenatal factors associated with autism spectrum disorder (ASD). ReprodToxicol 2015;56:155-69.
               87.  Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism--a current review of clinical and animal studies. Neurotoxicol
                   Teratol 2013;36:47-56.
               88.  Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
                   Neuropsychopharmacology 2005;30:80-9.
               89.  Yang EJ, Ahn S, Lee K, Mahmood U, Kim HS. Early behavioral abnormalities and perinatal alterations of PTEN/AKT pathway in
                   valproic acid autism model mice. PLoS One 2016;11:e0153298.
               90.  Kim JW, Seung H, Kim KC, Gonzales ELT, Oh HA, et al. Agmatine rescues autistic behaviors in the valproic acid-induced animal model
                   of autism. Neuropharmacology 2017;113:71-81.
               91.  Sheikh AM, Li X, Wen G, Tauqeer Z, Brown WT, et al. Cathepsin D, and apoptosis related proteins are elevated in the brain of autistic
                   subjects. Neuroscience 2010;165:363-70.
               92.  Tian Y, Yabuki Y, Moriguchi S, Fukunaga K, Mao PJ, et al. Melatonin reverses the decreases in hippocampal protein serine/threonine
                   kinases observed in an animal model of autism. J Pineal Res 2014;56:1-11.
               93.  Bozdagi O, Tavassoli T, Buxbaum JD. Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and
                   developmental delay. Mol Autism 2013;4:9.
               94.  van Echten-Deckert G, Hagen-Euteneuer N, Karaca I, Walter J. Sphingosine-1-phosphate: boon and bane for the brain. Cell Physiol
                   Biochem 2014;34:148-57.
               95.  Jang S, Kim D, Lee Y, Moon S, Oh S. Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety.
                   Neurochem Res 2011;36:258-67.
               96.  Wu H, Zhang Q, Gao J, Sun C, Wang J, et al. Modulation of sphingosine 1-phosphate (S1P) attenuates spatial learning and memory
                   impairments in the valproic acid rat model of autism. Psychopharmacology (Berl) 2018;235:873-86.
               97.  Zhang Y, Xiang Z, Jia Y, He X, Wang L, et al. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy, and
                   dendritic spine density abnormalities in a valproic acid-induced animal model of autism. Prog Neuropsychopharmacol Biol Psychiatry
                   2019;94:109644.
               98.  Al-Tawashi A, Jung SY, Liu D, Su B, Qin J. Protein implicated in nonsyndromic mental retardation regulates protein kinase A (PKA)
                   activity. J Biol Chem 2012;287:14644-58.
               99.  Manzini MC, Xiong L, Shaheen R, Tambunan DE, Costanzo SD, et al. CC2D1A regulates human intellectual and social function as well
                   as NF-κB signaling homeostasis. Cell Rep 2014;8:647-55.
               100. Zhao M, Raingo J, Chen ZJ, Kavalali ET. Cc2d1a, a C2 domain containing protein linked to nonsyndromic mental retardation, controls
                   functional maturation of central synapses. J Neurophysiol 2011;105:1506-15.
               101. Oaks AW, Zamarbide M, Tambunan DE, Santini E, Costanzo SD, et al. Cc2d1a loss of function disrupts functional and morphological
                   development in forebrain neurons leading to cognitive and social deficits. Cereb Cortex 2017;27:1670-85.
               102. Rogaeva A, Albert PR. The mental retardation gene CC2D1A/Freud-1 encodes a long isoform that binds conserved DNA elements to
                   repress gene transcription. Eur J Neurosci 2007;26:965-74.
               103. Vahid-Ansari F, Daigle M, Manzini MC, Tanaka KF, Hen R, et al. Abrogated freud-1/CC2D1A repression of 5-HT1Aautoreceptors
                   induces fluoxetine-resistant anxiety/depression-like behavior. J Neurosci 2017;37:11967-78.
               104. Basel-Vanagaite L, Attia R, Yahav M, Ferland RJ, Anteki L, et al. The CC2D1A, a member of a new gene family with C2 domains, is
                   involved in autosomal recessive non-syndromic mental retardation. J Med Genet 2006;43:203-10.
               105. Al-Tawashi A, Gehring C. Phosphodiesterase activity is regulated by CC2D1A that is implicated in non-syndromic intellectual disability.
                   Cell Commun Signal 2013;11:47.
               106. Zamarbide M, Mossa A, Muñoz-Llancao P, Wilkinson MK, Pond HL, et al. Male specific cAMP signaling in the hippocampus controls
                   spatial memory deficits in a mouse model of autism and intellectual disability. Biol Psychiatry 2019;85:760-8.
               107. Möhrle D, Fernández M, Peñagarikano O, Frick A, Allman B, et al. What we can learn from a genetic rodent model about autism.
                   NeurosciBiobehav Rev 2020;109:29-53.
   120   121   122   123   124   125   126   127   128   129   130